EYEGATE PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for EYEGATE PHARMACEUTICALS INC *W EXP 08/05/202, CUSIP 30233M115.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for EYEGATE PHARMACEUTICALS INC *W EXP 08/05/202, CUSIP 30233M115.